A. Selyutina

发表

Nuclear Import of the HIV-1 Core Precedes Reverse Transcription and Uncoating

A. Selyutina, Mirjana Persaud, Kyeongeun Lee, 2020, bioRxiv.

Nuclear Import of the HIV-1 Core Precedes Reverse Transcription and Uncoating

A. Selyutina, Mirjana Persaud, Kyeongeun Lee, 2020, Cell reports.

When biologist meets chemist: a search for HIV-1 inhibitors

A. Selyutina, 2015 .

Nuclear restriction of HIV-1 infection by SUN1

A. Selyutina, Mirjana Persaud, F. Diaz-Griffero, 2021, Scientific Reports.

Design, discovery, modelling, synthesis, and biological evaluation of novel and small, low toxicity s-triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.

U. Maran, A. Selyutina, A. García-Sosa, 2016, Bioorganic & medicinal chemistry.

Proteasome‐mediated cleavage of the Y‐box‐binding protein 1 is linked to DNA‐damage stress response

V. Evdokimova, A. Sorokin, L. Ovchinnikov, 2005, The EMBO journal.

TRIM5α Restriction of HIV-1-N74D Viruses in Lymphocytes Is Caused by a Loss of Cyclophilin A Protection

J. Hultquist, A. Selyutina, F. Diaz-Griffero, 2020, bioRxiv.

Antibacterial activity of the nitrovinylfuran G1 (Furvina) and its conversion products

T. Tenson, V. Hauryliuk, U. Mäeorg, 2016, Scientific Reports.

Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5.

Alon Herschhorn, J. Sodroski, A. Selyutina, 2018, Virology.

The proteolytic YB-1 fragment interacts with DNA repair machinery and enhances survival during DNA damaging stress

V. Evdokimova, A. Sorokin, L. Ovchinnikov, 2013, Cell cycle.

Synthesis of Novel Acyclic Nucleoside Analogues with Anti-Retroviral Activity

A. Selyutina, A. Paju, A. Merits, 2010, Nucleosides, nucleotides & nucleic acids.

Antiretroviral (HIV-1) activity of azulene derivatives.

A. Selyutina, A. Bredihhin, J. Peet, 2016, Bioorganic & medicinal chemistry.

Synthesis and Biological Activity of Bimorpholine and its Carbanucleoside

A. Selyutina, A. Merits, M. Lopp, 2011, Nucleosides, nucleotides & nucleic acids.

RNA Interference-Guided Targeting of Hepatitis C Virus Replication with Antisense Locked Nucleic Acid-Based Oligonucleotides Containing 8-oxo-dG Modifications

M. Karelson, M. Saarma, A. Selyutina, 2015, PloS one.

Nucleic acid binding by SAMHD1 contributes to the antiretroviral activity and is enhanced by the GpsN modification

Alexander B. Taylor, D. Ivanov, Baek Kim, 2021, Nature Communications.

The ability of SAMHD1 to block HIV-1 but not SIV requires expression of MxB.

T. Schaller, Baek Kim, A. Selyutina, 2019, Virology.

Cyclophilin A Prevents HIV-1 Restriction in Lymphocytes by Blocking Human TRIM5α Binding to the viral Core

N. Krogan, J. Hiatt, J. Hultquist, 2019, bioRxiv.

Biochemical detection of capsid in the nucleus during HIV-1 infection

A. Selyutina, F. Diaz-Griffero, 2021, STAR protocols.

K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α

E. Campbell, A. Selyutina, F. Diaz-Griffero, 2019, Journal of Virology.

Binding of host factors to stabilized HIV-1 capsid tubes.

A. Selyutina, F. Diaz-Griffero, Á. Bulnes-Ramos, 2018, Virology.

GS-CA1 and lenacapavir stabilize the HIV-1 core and modulate the core interaction with cellular factors

J. Hultquist, A. Selyutina, Kyeongeun Lee, 2021, iScience.

1 1 TRIM 5 α restriction of HIV-1N 74 D viruses in lymphocytes is 2 caused by a loss of cyclophilin A protection 3 4 5

J. Hultquist, A. Selyutina, F. Diaz-Griffero, 2022 .

Synthesis of Novel Saccharide Hydrazones

S. Türk, U. Mäeorg, A. Selyutina, 2015 .

Cyclophilin A Prevents HIV-1 Restriction in Lymphocytes by Blocking Human TRIM5α Binding to the Viral Core.

N. Krogan, J. Hiatt, J. Hultquist, 2020, Cell reports.